Skip to main content
SpringerLink
Log in

Epirubicin

  • Chapter
Extravasation of Cytotoxic Agents

  • 945 Accesses

Abstract

1. Stop injection/infusion immediately

2. Get extravasation kit

3. Put on (sterile) gloves

4. Replace infusion lead or syringe with 5 ml disposable syringe and aspirate slowly as much as possible of the extravasated drug; Cave! do not exert pressure on extravasation area

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Log in via an institution
Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 84.99
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 159.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

Original articles

  1. Bertelli G, Dini D, Forno G, et al: Dimethylsulphoxide and cooling after extravasation of antitumour agents. Lancet 341: 1098–1099, 1993.

    Article  Google Scholar 

  2. Bertelli G, Gozza A, Forno GB, et al: Topical dimethylsulfoxide for the prevention of soft tissue injury after extravasation of -vesicant cytotoxic drugs: a prospective clinical study. J Clin Oncol 13: 2851–2855, 1995.

    Google Scholar 

  3. Kappel B, Hindenburg AA, Taub RN: Treatment of anthracycline extravasation – a warning against the use of sodium bicarbonate. J Clin Oncol 5: 825–826, 1987.

    PubMed  CAS  Google Scholar 

  4. Tsavaris NB, Karagiaouris P, Tzannou I, et al: Conservative -approach to the treatment of chemotherapy-induced extravasation. J Dermatol Surg Oncol 16: 519–522, 1990.

    PubMed  CAS  Google Scholar 

  5. Tsavaris NB, Komitsopoulou P, Karagiaouris P, et al: Prevention of tissue necrosis due to accidental extravasation of cytostatic drugs by a conser-vative approach. Cancer Chemother Pharmacol 30: 330–333, 1992.

    Article  PubMed  CAS  Google Scholar 

  6. Dini D, Forno G, Gozza A, et al: Combined management in the treatment of epidoxorubicin extravasation: a case report. Support Care Cancer 3: 150–152, 1995.

    Article  PubMed  CAS  Google Scholar 

  7. Bos AME, van der Graaf WTA, Willemse PHB: A new conservative approach to extravasation of anthracyclines with dimethylsulfoxide and dexrazoxane. Act Oncol 40: 541–542, 2001.

    Article  CAS  Google Scholar 

  8. Langer SW, Sehested M, Jansen PB, et al: Dexrazoxane in anthracycline extravasation. J Clin Oncol 18: 3064, 2000.

    PubMed  CAS  Google Scholar 

  9. Bozkurt AK, Uzel B, Akman C, et al: Intrathoracic extravasation of antineoplastic agents. Am J Clin Oncol 26: 121–123, 2003.

    Article  PubMed  Google Scholar 

  10. ouridsen HT, Langer SW, Buter J, et al: Treatment of anthracycline extravasation with Savene (dexrazoxane): results from two prospective cilinical multicentre studies. Ann Oncol 18: 546-550, 2007.

    Article  Google Scholar 

  11. Parikh PM, Ranjan S, Swami A, et al: Phlogenzym® is safe and -effective in reducing morbidity of vesicant chemotherapy extravasation. A prospective study. Int J Immunother 17: 163–170, 2001.

    CAS  Google Scholar 

Secondary literature

  1. Bertelli G: Prevention and management of extravasation of cytotoxic drugs. Drug Safety 12: 245–255, 1995.

    Article  PubMed  CAS  Google Scholar 

  2. Schneider G: Paravasate von Zytostatika. Diagnostik und Therapie. Aina S. Schneider Verlag, 6th edition: 1–17, 1999.

    Google Scholar 

  3. Krämer I, Stützle M: Zytostatika-Paravasation – Wie ist vorzugehen? Krankenhauspharmazie 23: 261–268, 2002.

    Google Scholar 

  4. Gain M, Melzer S, Meyer-Jürshof A, et al: Epirubicin: Behandlung von Paravasaten. In: Gain M, et al (eds) ADKA-Zytostatika-Handbuch, Pharmazeutisch-wissenschaftliche Monographien. Verlag Heiner Biller, vol 6: 37–38, 2002.

    Google Scholar 

  5. Dorr RT, Von Hoff DD: Drug monographs: epirubicin. In: Dorr RT, Von Hoff DD (eds) Cancer Chemotherapy Handbook. Appleton & Lange, 2nd edition: 434–439, 1994.

    Google Scholar 

  6. Stanley A: Managing complications of chemotherapy administration. In: Allwood M, Stanley A, Wright P (eds) The Cytotoxics Handbook. Radcliffe Medical Press, 4th edition: 119–193, 2002.

    Google Scholar 

  7. Mullin S, Beckwith MC, Tyler LS: Prevention and management of antineoplastic extravasation injury. Hosp Pharm 35: 57–76, 2000.

    Google Scholar 

  8. Kraft A, Weinig S, Edinger M, et al: Anthrazyklin-Extravasate. Der Onkologe 6: 674–686, 2000.

    Article  Google Scholar 

  9. Dorr RT: Antidotes to vesicant chemotherapy extravasations. Blood Rev 4: 41–60, 1990.

    Article  PubMed  CAS  Google Scholar 

  10. Jordan K, Grothe W, Schmoll HJ: Paravasation von Zytostatika: Prävention und Therapie. Dtsch Med Wochenschr 130: 33–37, 2005.

    Article  PubMed  CAS  Google Scholar 

  11. Ener RA, Meglathery SB, Styler M: Extravasation of systemic hemato-oncological therapies. Ann Oncol 15: 858–862, 2004.

    Article  PubMed  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. CRETA – Cancer Research & Trial Agency GmbH, Bad Sauerbrunn, Österreich

    Ines Mader MD

  2. Krankenhaus und Geriatriezentrum, SMZ Floridsdorf, Wien, Österreich

    Mag. pharm. Patrizia Fürst-Weger

  3. Klinische Abteilung für Onkologie, Univ.-Klinik für Innere Medizin I, Wien, Österreich

    Univ.-Prof. Dr. Robert Mader

  4. Anstaltsapotheke, Landeskrankenhaus – Universitätskliniken Innsbruck, Innsbruck, Österreich

    Mag. pharm. Dr. Elisabeth Nogler-Semenitz

  5. Apotheke LKH-Univ.-Klinikum Graz, Graz, Österreich

    Mag. pharm. Sabine Wassertheurer

Authors
  1. Ines Mader MD
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Mag. pharm. Patrizia Fürst-Weger
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Univ.-Prof. Dr. Robert Mader
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Mag. pharm. Dr. Elisabeth Nogler-Semenitz
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. Mag. pharm. Sabine Wassertheurer
    View author publications

    You can also search for this author in PubMed Google Scholar

Rights and permissions

Reprints and permissions

Copyright information

© 2010 Springer-Verlag/Wien

About this chapter

Cite this chapter

Mader, I., Fürst-Weger, P., Mader, R., Nogler-Semenitz, E., Wassertheurer, S. (2010). Epirubicin. In: Extravasation of Cytotoxic Agents. Springer, Vienna. https://doi.org/10.1007/978-3-211-88893-3_31

Download citation

  • DOI: https://doi.org/10.1007/978-3-211-88893-3_31

  • Publisher Name: Springer, Vienna

  • Print ISBN: 978-3-211-88889-6

  • Online ISBN: 978-3-211-88893-3

  • eBook Packages: MedicineMedicine (R0)

Publish with us

Policies and ethics

Search

Navigation